Trial intelligence / Profile preview

Oral vs intravenous tranexamic acid in total hip arthroplasty

2020-004167-29Phase 4Completed

Sponsor
Centre Hospitalier Universitaire de Liège
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tranexamic acid in perioperative bleeding (2 arms), sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoint: Perioperative blood loss within 48 hours. Started Feb 2021; status: completed.

02

Drugs

tranexamic acid
03

Conditions

perioperative bleeding

Beyond the preview

Go deeper on 2020-004167-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-004167-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call